?? Get the latest developments in clinical supply chain & logistics delivered to your inbox weekly: https://lnkd.in/d6NKbrNt Clinical Supply Leader will help you pinpoint inefficiencies in your supply chain, stay up to date on regulatory changes, identify potential supplier partners, and much more. Join our community today!
Clinical Supply Leader
互联网出版
Cranberry Township，Pennsylvania 1,032 位关注者
A trusted source for those professionals ensuring a secure clinical supply chain from drug development to post-trial.
关于我们
Clinical Supply Leader is a Life Science Connect community dedicated to facilitating seamless collaboration between key functional roles at the intersection of the clinical trial supply chain and logistics. With a primary focus on clinical operations and supply chain experts, we understand that these disciplines must collaborate to ensure the success of clinical supply management. Our community is committed to being a resource for tailored expertise and valuable insights curated to empower those entrusted with the secure, precise, and punctual delivery of life-saving treatments to patients at their respective clinical sites. We also emphasize the efficient management of product returns, reconciliation, and disposal, ensuring every aspect of the clinical supply chain is addressed securely. From the earliest stages of drug development to the intricacies of post-trial processes we cover all aspects of the clinical supply chain and logistics, from the early stages of drug development to post-trial processes.
- 网站
-
https://www.clinicalsupplyleader.com/
Clinical Supply Leader的外部链接
- 所属行业
- 互联网出版
- 规模
- 51-200 人
- 总部
- Cranberry Township，Pennsylvania
- 领域
- life sciences、clinical supply、clinical supply chain和clinical supply logistics
动态
-
Of the 190 warning letters that the FDA issued to drug and biopharma manufacturers in fiscal year 2024, this article provides a deep dive on trends pertinent to the 111 inspection-based letters. https://lnkd.in/ewPDPEGT By Elizabeth Oestreich, Kalah Auchincloss, and Erin Hartmann, ELIQUENT Life Sciences
-
Data is the single most important thing in a clinical trial. Learn how to leverage the power of clinical trial data with effective utilization and access in a changing regulatory landscape. https://lnkd.in/eVGjH8xF By James Stringer, Signant Health
-
Tumor-infiltrating lymphocyte cell therapy shows promise for treating solid tumors, but its complex manufacturing profile brings a unique set of issues. Here are some things to watch out for: https://lnkd.in/eGrVW3HB By Liang L., Resilient Collective
-
Investing in employee training and development is not just beneficial for the employees. It also contributes significantly to the organization’s success and competitive advantage. Learn more: https://lnkd.in/eW2v_rdZ By Jenny Minigh, PhD, inSeption Group
-
Gates Medical Research Institute's head of clinical supply, Seth Thompson, discusses learnings and considerations that he keeps in mind for clinical trial supply chain/logistics. https://lnkd.in/eWvXqZzQ
-
Clinical trials continue to face challenges related to cost, patient technology adoption, and resource management. Uncover how investing in suitable tech solutions can enhance efficiency and reduce companies' carbon footprint. https://lnkd.in/eiKCp_4C By Kevin Landells, Vice President and General Manager, IQVIA IRT
-
The World Health Organization estimates that at least 1 in 10 medicines in low- and middle-income countries are substandard or falsified, resulting in $30.5 billion in annual losses. This highlights the urgent need for more efficient and reliable medical supply chains. As the use of AI and drones grows, these technologies are reshaping the medical supply chain, offering new solutions to long-standing problems.?https://lnkd.in/eB9t6xri By Joseph Pategou
-
Looking ahead, the evolution of RTSM in clinical trials points towards cloud-based solutions, heightened emphasis on patient safety, and greater collaboration among stakeholders. Learn how you can prepare: https://lnkd.in/e6Tj22rZ By Ian Davison, RTSM Subject Matter Expert, and Marc Weinberg, Senior Director of RTSM, Medrio
-
The FDA’s draft guidance, published in January, introduces a 7-step framework to ensure AI models used in drug development are robust, reliable, and meet regulatory standards. Fahimeh Mirakhori MSc., Ph.D. reviews the 7 steps: https://lnkd.in/eHXeFFux